The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global medical device testing market grew at a CAGR of around 6% during 2015-2020. Looking forward, IMARC Group expects the market to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Medical device testing refers to the process of inspecting the design and production efficiency of various active and non-active medical equipment. It involves prototype, biocompatibility, chemistry, microbiology and sterility testing, package validation, electrical, mechanical and functional safety assessments and software testing. These tests are conducted for cardiovascular, neuro and orthopedic devices, dental implants and material components. The service providers also offer in-house or outsourced testing, inspection and certification services to the consumers. These services ensure that the device is reliable and safe to use in clinical or emergency settings. As a result, medical device testing finds extensive applications across hospitals, clinics and other healthcare and diagnostic centers.
Significant growth in the medical industry, along with the increasing requirement of validation and verification of medical devices, represents one of the key factors creating a positive outlook for the market. Moreover, as the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for efficient testing systems to develop low-cost medical devices which is further augmenting the market growth. Additionally, various technological advancements, such as the utilization of artificial intelligence (AI), robotics and automation in the testing processes, are acting as other major growth-inducing factors. Device manufacturers use automated quality assurance tools to increase the accuracy of clinical equipment and wearable medical devices with minimal human intervention in the testing processes. Other factors, such as increasing complexities in product design, along with the widespread adoption of outsourced testing services, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global medical device testing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on service, type, testing type, device class and device type.
Breakup by Service:
Breakup by Type:
Breakup by Testing Type:
Breakup by Device Class:
Breakup by Device Type:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being American Preclinical Services LLC, Charles River Laboratories Inc., Element Materials Technology, Eurofins Scientific LLC, Intertek Group Plc, North American Science Associates Inc., Pace Analytical Services LLC (LAB Holdings Inc.), SGS SA, Sterigenics U.S. LLC (Sotera Health LLC), Toxikon Corporation, TÜV Rheinland Aktiengesellschaft, TÜV SÜD Aktiengesellschaft and WuXi AppTec.
|Base Year of the Analysis||2020|
|Segment Coverage||Service, Type, Testing Type, Device Class, Device Type, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||American Preclinical Services LLC, Charles River Laboratories Inc., Element Materials Technology, Eurofins Scientific LLC, Intertek Group Plc, North American Science Associates Inc., Pace Analytical Services LLC (LAB Holdings Inc.), SGS SA, Sterigenics U.S. LLC (Sotera Health LLC), Toxikon Corporation, TÜV Rheinland Aktiengesellschaft, TÜV SÜD Aktiengesellschaft and WuXi AppTec.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at